A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)

This study has been completed.

Sponsor:

ClinicalTrials.gov Identifier:

NCT00424788

First Posted: January 22, 2007

Last Update Posted: September 4, 2009

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Information provided by:

Biogen

Study Status:	This study has been completed.
Study Completion Date:	October 2007
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)

Study Status:

This study has been completed.

Study Completion Date:

October 2007

Primary Completion Date:

October 2007 (Final data collection date for primary outcome measure)